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Abstract
The goals of this study were to document the proliferative response of intestinal stem cells (ISCs) 
during regeneration after damage from doxorubicin (DXR) and to characterize the signals 
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responsible for ISC activation. To this end, jejuni from DXR-treated mice were harvested for 
histology, assessment of ISC numbers and proliferation by flow cytometry, crypt culture, and 
RNA analyses. Histology showed that crypt depth and width were increased 4 days after DXR. At 
this time point, flow cytometry on tissue collected 1 hour after EdU administration revealed 
increased numbers of CD24loUEA− ISCs and increased percentage of ISCs cycling. In culture, 
crypts harvested from DXR-treated mice were equally proliferative as those of control mice. 
Addition of subepithelial intestinal tissue (SET) collected 4 days after DXR elicited increased 
budding (1.4 ± 0.3 vs. 5.1 ± 1.0 buds per enteroid). Microarray analysis of SET collected 4 days 
after DXR revealed 1,030 differentially expressed transcripts. Cross comparison of Gene Ontology 
terms considered relevant to ISC activation pointed to 10 candidate genes. Of these the epidermal 
growth factor (EGF) family member amphiregulin and the BMP antagonist chordin-like 2 were 
chosen for further study. In crypt culture, amphiregulin alone did not elicit significant budding, but 
amphiregulin in combination with BMP antagonism showed marked synergism (yielding 6.3 ± 0.5 
buds per enteroid). These data suggest a critical role for underlying tissue in regulating ISC 
behavior after damage, and point to synergism between amphiregulin and chordin-like 2 as factors 
which may account for activation of ISCs in the regenerative phase.
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Introduction
Intestinal stem cells (ISCs), located in the lower portions of the crypts of Lieberkühn, are 
responsible not only for intestinal epithelial development and maintenance of epithelial 
homeostasis but also for restitution of epithelial integrity and function following damage or 
challenge. Current literature suggests there are two broad categories of ISCs: an actively 
cycling population found at the crypt base and marked by Lgr5; and one (or more) relatively 
quiescent population(s) located a little higher in the crypt (Barker, et al., 2012, Carlone and 
Breault, 2012, King and Dekaney, 2013, Potten, et al., 2009, Shaker and Rubin, 2010). The 
former, herein designated “active ISCs”, are believed to be primarily responsible for daily 
turnover of the epithelium under homeostatic conditions, whereas the latter, designated 
“reserve ISCs”, appear to function as a source of epithelial replacement and crypt 
regeneration after intestinal damage. Better understanding of factors that regulate ISC 
behavior will enlighten future treatment across multiple clinical scenarios. These include, 
but are not limited to: chemotherapy or radiation-induced mucositis, ischemia-reperfusion 
injury, short bowel syndrome, IBD/intestinal inflammation, intestinal polyposis syndromes, 
and cancer.
As has been previously reported, the commonly used chemotherapeutic agent doxorubicin 
(DXR) rapidly induces apoptosis in the ISC zone (Dekaney, et al., 2009, Ijiri and Potten, 
1987). This causes epithelial damage including crypt loss and villus blunting, followed by 
epithelial regeneration (Dekaney, et al., 2009). A key component of the repair phase is 
restoration of crypt number, which occurs by the process of crypt fission. Prior studies 
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suggest that crypt fission may be driven by activation of reserve ISCs (Buczacki, et al., 
2013, Dekaney, et al., 2009), however data on ISC proliferation were not provided in these 
reports. Thus, the first goal of our study was to use quantitative flow cytometric analysis 
following administration of the thymidine analog EdU to directly assess ISC proliferation 
following damage by DXR.
During both homeostasis and response to damage, the stem cell niche is recognized as 
providing key regulatory signals to the ISCs (Scoville, et al., 2008, Shaker and Rubin, 2010, 
Smith, et al., 2012, Tan and Barker, 2014, Yu, 2013). The niche includes epithelial elements, 
such as Paneth cells, which are known to secrete multiple factors capable of enhancing ISC 
proliferation (Clevers and Bevins, 2013), as well as subepithelial elements, such as 
myofibroblasts, which secrete both stimulatory and inhibitory factors (Powell, et al., 2011, 
Ye Lei, et al., 2014). While the complex interplay of niche components with ISCs has been 
widely studied following radiation damage (Yu, 2013), there is a dearth of literature on the 
regulation of ISC behavior following damage by chemotherapeutic drugs. This represents a 
major gap in current knowledge of ISCs. Therefore, our second goal was to assess the 
relative contributions of the crypt epithelium and the underlying tissue, hereafter referred to 
as sub-epithelial tissue (SET) in eliciting ISC proliferation after DXR-induced damage. We 
hypothesized that following cytotoxic damage, ISCs rely on signals from either the crypts 
themselves and/or from the SET, to proliferate and drive crypt fission, thus regenerating the 
epithelium. This hypothesis was tested using a crypt culture system in which crypts were 
grown alone or in combination with SET. Candidate ISC-regulating factors secreted by SET 
in vivo were identified by transcriptome analysis and then tested in crypt culture.
Materials and Methods
Damage and repair after DXR: animals, tissue processing, and histology
Animal experiments were performed with permission of our IACUC. Mice were housed 
under a 12:12-h light-dark cycle in American Association for Accreditation of Laboratory 
Animal Care-approved facilities. After acclimation to our facility for ≥ 1 week, 20–25 week 
old male C57BL/6J mice (Jackson Laboratories, Bar Harbor, HE, USA) were injected IP 
with DXR (15 mg/kg). Following injection, animals were provided fresh water and fed 
standard chow with liquid diet supplementation of Nutren 1.0 with Fiber (Nestlé Health 
Science, Florham Park, NJ, USA) diluted 2:1 with water. Control mice (uninjected) were 
maintained on this diet for an equivalent length of time. Mice were weighed daily and 
sacrificed at 2 day intervals, up to 8 days, after DXR injection. At sacrifice, jejunal tissue 
was harvested, flushed with ice-cold PBS and cut into 1cm lengths. The majority (approx. 
18) of these pieces were placed into ice-cold PBS for crypt harvest and SET-co-culture 
(below). One piece from the mid-jejunum was incubated in zinc formalin at RT overnight, 
and then stored in 70% EtOH at RT until embedded in paraffin, sectioned into 5μm sections 
(separated by 100μm intervals) and stained with hematoxylin and eosin (H&E) for 
morphological assessment. Another piece from mid-jejunum was filleted open and placed 
into ice-cold PBS for complete epithelial dissociation to generate SET for RNA isolation. 
Histological measurements from H&E stained tissues were taken by a blinded scorer using 
Image J software (5 sections scored per biological replicate, ≥ 3 biological replicates per 
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time point); To quantitate crypt fission, 100 well orientated crypts were examined from each 
mouse. Crypt fission was defined as a bifurcating crypt with a fissure creating two (or 
sometimes more) flask-shaped bases with a shared single crypt-villus junction. For all 
histologic data, statistical comparisons of each time point with Day 0 were performed using 
one-way ANOVA with Tukey multiple comparison test.
Assessment of ISC cycling activity after DXR by flow cytometry
Jejunal epithelial cells were isolated from untreated and Day 4 DXR-treated mice using an 
EDTA/Dispase method, 1 h after IP injection of EdU (100ug/20g BW) as described 
previously (von Furstenberg, et al., 2011). 1 million cells from the single cell suspension 
were incubated in 100 μl PBS with no antibody, UEA-488 (1:500), or anti-CD24-PB 
(0.25μg/ml), and the EdU coupled with azide Alexa-647 dye following fixation and 
permeabilization using reagents and methods as reported previously (von Furstenberg, et al., 
2011). Cells were analyzed by using a Beckman-Coulter CyAn ADP (Dako, Carpinteria, 
CA). Debris and CD45+ cells were excluded based on size via bivariate plot of forward 
scatter (FSC) versus side scatter (von Furstenberg, et al., 2011). Doublets were excluded by 
successive gating on both a bivariate plot of pulse-width vs. FSC, and a bivariate plot of 
FSC area vs. FSC linear. Fluorescence minus one controls were used to establish gates to 
measure labeled cells (Roederer, 2001). Statistical comparisons of cell populations in DXR-
treated vs. control mice were performed using unpaired t-tests (two-tailed).
Crypt culture
Crypts were isolated from jejuni of C57BL/6J mice via incubation in 5mM EDTA in PBS at 
4°C × 30min on an orbital platform, followed by gentle hand shaking in ice-cold PBS and 
filtration through a 70 μm cell strainer in a manner similar to Sato et al. (Sato, et al., 2009). 
This crypt-enriched fraction was then pelleted by centrifugation and resuspended in hESC-
qualified Matrigel (BD, San Jose, CA, USA) containing the anoikis inhibitor Y27632 
(Sigma, St. Louis, MO) at a concentration of 10μM and culture factors epidermal growth 
factor (EGF) at 50ng/mL, noggin at 100ng/mL and R-spondin-1 at 500ng/mL, as originally 
reported by Sato et al. (Sato, et al., 2009) and previously described by Fuller et al. (Fuller, et 
al., 2013). Variations in the standard culture factors are indicated in the figure legends. 
Matrigel aliquots (10 μl per well containing 60–100 crypts) were plated onto 48-well culture 
plates (Costar, Washington, DC, USA). Plates were incubated at 37°C for 30min for 
Matrigel polymerization, and 200 μl per well of culture media was added containing 
Advanced DMEM/F12 supplemented with GlutaMAX (2mM), gentamycin/kanamycin 
(1:100), amphotericin B (0.25μg/mL), HEPES (10mM), N2 (1:100) and B27 (1:50). On the 
day of plating, the number of crypts per well was manually counted under bright field 
microscopy. Plates were then incubated at 37°C, and culture media was changed every 2 
days, including supplementation with indicated culture factors to achieve original plating 
concentrations. There were ≥ 4 technical replicates per condition tested.
After 7 days in culture, the numbers of enterospheres and enteroids, as defined by the 
Intestinal Stem Cell Consortium (Stelzner, et al., 2012) were counted. Crypt survival per 
well was calculated as the total number of surviving structures (enterospheres or enteroids) 
divided by the original number of crypts plated in that well. The number of buds on each 
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surviving structure was counted under bright field microscopy. Enterospheres that survived 
but failed to progress to enteroids were assessed a bud number of 0. The average bud 
number per well was calculated as the total number of buds divided by the total number of 
surviving enteroids and enterospheres per well. Average bud counts from the technical 
replicates for each mouse were then used to calculate means ± SEM for numbers of mice 
(biological replicates) shown in figure legends. Statistical analysis for Fig. 3 was via 
unpaired t-tests (two-tailed).
For SET co-culture experiments, crypts were isolated from jejuni of DXR-treated mice and 
untreated controls, and resuspended at equal concentrations into Matrigel containing only R-
spondin-1. Remnant tissue from the crypt isolation was then shaken aggressively to remove 
epithelium and yield SET. The SET was minced finely and added at a concentration of 1.0–
1.5 μL minced SET per 50 μL Matrigel-crypt suspension prior to plating and further culture, 
as described above. After 7 days, bud numbers were quantified as previously described. 
Statistical analysis for Fig. 4 was as follows: t-test (two-tailed) was performed to compare 
condition A to B; paired t-tests were performed to compare condition A to C, condition A to 
D, and condition C to D.
In order to study the effects of amphiregulin and noggin, crypts were isolated and plated in 
Matrigel containing R-spondin-1, as above, in addition to either: A. no further additions; B. 
recombinant mouse amphiregulin (R&D, Minneapolis, MN, USA) at 100ng/mL (final 
concentration); C. noggin at 100ng/mL (final concentration); or D. both amphiregulin and 
noggin. Bud numbers were quantified after 7d in culture. Statistical analysis was performed 
using two-way ANOVA, with post-hoc one-way ANOVA with Tukey multiple comparison 
test.
To assess the potency of chordin-like 2 as compared with noggin, crypts were grown in 
Matrigel containing R-spondin-1 and amphiregulin as above in addition to either noggin or 
chordin-like 2 at concentrations of 0,10,100, or 200 ng/mL. Bud numbers were quantified 
after 7d in culture. Statistical analysis was performed using two-way ANOVA.
Microarray analysis, Gene Ontology and qRT-PCR
SET was stored at 4°C in RNA later (Qiagen, Venlo, Limburg) then removed and 
homogenized in a solution of 1:100 β-mercaptoethanol to Buffer RLT Plus (Qiagen, Venlo, 
Limburg) in Lysing Matrix tubes on a FastPrep-24 (MP biomedicals, Santa Ana, CA). 
Lysates were centrifuged and RNA was extracted from the supernatant using the RNeasy 
Plus Mini Kit (Qiagen, Venlo, Limburg). RNA from 8 biological replicates per condition (8 
SET from untreated controls and 8 SET from day 4 after DXR mice) was submitted for 
microarray. RNA quality and concentration were assessed using a 2100 Bioanalyzer 
(Agilent, Santa Clara, CA, USA) and NanoDrop Spectrophotometer prior to submission to 
the UNC Functional Genomics Core, where total RNA (250 ng) was used to synthesize 
fragmented and labeled sense-strand cDNA and hybridized onto Affymetrix Mouse Gene 
2.1 ST arrays (16-array plate). The Affymetrix HT WT User Manual (Santa Clara, CA, 
USA) was followed to prepare the samples. Partek Genomics Suite 6.6 (Partek Inc., St. 
Louis, MO) was used to perform data analysis. Robust multi-chip analysis (RMA) 
normalization was done on the entire data set. Multi-way ANOVA and fold change were 
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performed to select target genes that were differentially expressed between DXR SET and 
untreated SET. Top differentially expressed genes were selected with p value cutoff of <0.05 
based on ANOVA test and 2-fold change cutoff. Hierarchical Clustering was performed on 
differentially expressed genes based on Average Linkage with Pearson’s Dissimilarity. Gene 
Ontology enrichment analysis on the gene lists were performed using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID). To determine GO term 
enrichment, the proportion of test genes that mapped to a particular GO term was compared 
with the proportion of genes from the entire GeneChip that mapped to the same term. 
Enriched biological process and cellular component terms shown had a p-value and FDR 
cutoff of <0.05. The selected regenerative candidate terms in the cross-comparison met the 
criteria of p-value <0.05.
To validate the microarray data and examine the time course of expression of selected 
transcripts in SET following DXR treatment, RNA was prepared from SET collected at day 
0, 2, 4, 6, and 8 after DXR injection. For high throughput qRT-PCR, cDNA was synthesized 
from RNA, amplified, and included for gene expression analysis using the Fluidigm 
BioMark HD system according to the manufacturer’s instructions (Fluidigm Corporation, 
South San Francisco, CA). TaqMan probes [Areg (Mm00437583_m1), Ereg 
(Mm00514794_m1), Tgfa (Mm00446232_m1), EGF (Mm00438696_m1)], Chrdl2 
(Mm00505094_m1), Grem1 (Mm00488615_s1), and Nog (Mm01297833_s1) were obtained 
from Life Technologies (Grand Island, NY, USA) and used according to the manufacturer’s 
protocol. β-Actin was used as an internal control, and fold changes were obtained using the 
comparative [delta][delta]Ct method. mRNA fold changes of the DXR treated groups (day 
2, 4, 6, 8 following administration) were then normalized to corresponding day 0 (untreated) 
values, setting the control fold change to a baseline value of 1. One-way ANOVA was 
performed to assess statistical significance of these mRNA fold changes across the time 
points.
Results
The regenerative response to damage becomes evident by 4 days after DXR
As expected, treatment with DXR produced mucositis in our mice, associated with weight 
loss and changes in crypt number/crypt morphology. Following IP injection, the weight loss 
was rapid in the first 4 days, then plateaued (Fig. 1a). Crypt loss occurred, wherein the 
number of crypts per transverse jejunal circumference declined significantly by day 4 after 
DXR (Fig. 1b); this was accompanied by a decline in total jejunal circumference, though 
this did not reach significance (Fig. 1c). By day 4 after DXR, there was morphological 
evidence of crypt regeneration, with increased crypt depth (Fig. 1d), and width (Fig. 1e). 
This was followed by a significant increase in the rate of crypt fission at day 8 (Fig. 1f), 
indicating a definitive stage of damage recovery. Representative histology is shown in Fig. 
1g at low power and at high power in Supplemental Fig. 1. Collectively, these data led us to 
further characterize events occurring at day 4 after DXR, as this seemed a likely time point 
in which regenerative signaling to ISCs would be strong.
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ISC numbers and proliferation status are elevated 4 days after DXR
Previous work from our laboratory has shown that following staining of epithelial 
preparations with CD24, both ISCs and Paneth cells are found in the CD24lo fraction 
identified by flow cytometry (von Furstenberg, et al., 2011). Wong et al. subsequently 
demonstrated that the lectin UEA can be used to remove Paneth cells. (Wong, et al., 2012). 
Thus, in the current work, flow cytometry was used to exclude UEA+ cells; the UEA− 
population was then plotted as CD24 vs. EdU (to identify cycling cells). Representative flow 
plots are shown in Fig. 2a and the labeling strategy is shown in Fig. 2b. There was an 
expansion in the absolute pool of ISCs (both cycling and non-cycling): ISCs represented 4.9 
± 1.0% of all epithelial cells at day 4 after DXR vs 2.2 ± 0.6% in untreated controls (Fig. 
2c). This was accompanied by increased cycling activity of ISCs at day 4 after DXR: 37 ± 
6% of ISCs were cycling at this time point, as compared to 17 ± 4% in untreated controls 
(Fig. 2d). Interestingly, this expansion in cycling activity demonstrated a preserved ratio 
between cycling transit amplifying (TA) cells and cycling ISCs (Fig. 2e); 4 days after DXR 
28 ± 5% of EdU+ epithelial cells were ISCs and 72 ± 5% of EdU+ cells were TA cells (vs. 
27 ± 3% and 73 ± 3%, respectively, in untreated controls). Overall, these findings point to 
day 4 after DXR as a time in which ISCs were more actively cycling, and potentially 
responding to regenerative niche stimuli.
A minimalistic crypt culture system to study crypt responses to exogenous stimuli
In order to explore the origin of regenerative signals to the intestinal epithelium following 
DXR damage we needed a culture system in which crypts maintained adequate and 
reproducible survival, but minimal budding such that the enhanced proliferation could be 
easily measured. Thus, the standard culture conditions (Sato, et al., 2009) were modified as 
shown in Fig. 3. As can be seen, with R-spondin-1 only there was good survival after 7 days 
but minimal budding. Notably, there was an absolute requirement for R-spondin-1, as the 
absence of this factor yielded enterospheres by 24h (data not shown), but 0% survived by 7 
days in culture (Fig. 3a). These data highlighted an important consideration moving forward: 
by minimizing buds per enteroid while maintaining a reasonable survival, minimalistic 
culture conditions allow easier testing of potential pro-proliferative factors.
Crypts isolated from regenerating intestine are not endogenously more proliferative
Fig. 4, panels a and b show the behavior of crypts isolated from control mice as compared 
with mice on day 4 following DXR. As expected, crypts harvested from untreated control 
mice were minimally proliferative in these culture conditions (1.4 ± 0.3 buds per enteroid). 
Because ISCs showed enhanced proliferation in vivo 4 days after DXR (Fig. 2), we 
hypothesized that crypts isolated from DXR-treated mice would demonstrate increased 
budding in culture. Surprisingly this was not observed, as crypts from these mice were also 
minimally proliferative (1.2 ± 0.3 buds per enteroid).
Sub-epithelial tissue isolated from regenerating intestine increases crypt budding
Fig. 4, panels c and d show the behavior of control crypts co-cultured with SET from either 
control mice (c) or day 4 DXR-treated mice (d). As can be seen from the comparison of 
panels a and c, co-culture with SET from control mice modestly enhanced proliferation as 
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assessed by budding behavior (1.4 ± 0.3 vs. 2.7 ± 0.2 buds per enteroid). Comparison of 
panels c and d shows that co-culture of SET harvested from mice 4 days after DXR yielded 
an additional significant increase in budding of control crypts (5.1 ± 1.0 buds per enteroid). 
This suggested that SET releases stimuli which induce epithelial proliferation, and that these 
signals are heightened during repair from cytotoxic injury.
Transcriptome analysis reveals regenerative signals originating from SET after damage
Microarray analysis performed on RNA extracted from SET harvested from mice 4 days 
after DXR as compared to untreated controls revealed 1030 differentially regulated genes 
(listed in Supplemental Table 1). Hierarchical clustering showed clear distinctions between 
treatment groups (Fig. 5). Overall GO analysis of biological processes (Fig. 6a) showed 
enrichment for transcripts expected to be associated with response to damage (e.g. “response 
to stimulus”, “response to stress”, etc.) and immune infiltration (“inflammatory response”) 
as well as those associated with repair (e.g. “cell cycle”, “M phase”, etc.). Within the 
cellular component arm of GO, the 2 most abundant categories were “extracellular region” 
and “extracellular space” (Fig. 6b), consistent with SET being highly secretory, as already 
deduced from the co-culture experiment. In order to identify specific candidate genes, the 
GO terms “binding,” “extracellular region,” and “tissue development” were considered 
relevant to ISC activation. As can be seen in Fig. 6c, when these were combined a total of 10 
genes emerged. Of these (shown in Fig. 6d), the most up-regulated was the EGF family 
member amphiregulin, (7.53 fold enriched) and the third highest was the BMP antagonist 
chordin-like 2 (4.5 fold enriched). Given the growing body of literature implicating 
amphiregulin in intestinal epithelial regulation (Hitch, et al., 2012, Shao and Sheng, 2010), 
and mounting evidence that ErbB receptor status may regulate ISC activation (Powell, et al., 
2012, Wong, et al., 2012), we selected amphiregulin as an attractive candidate to test in 
culture for its ability to elicit crypt proliferation. Further, in view of the elevated expression 
of chordin-like 2, we explored the potential beneficial role of concomitant BMP antagonism.
Amphiregulin increases crypt budding in vitro provided BMP signaling is inhibited
To assess the proliferative capacity of amphiregulin in our enteroid culture system, crypts 
were grown under minimal conditions (as in Fig. 3) with the addition of either amphiregulin 
alone or amphiregulin in combination with noggin which is the standard BMP antagonist 
traditionally used in enteroid cultures (Sato and Clevers, 2013). Despite the fact that 
amphiregulin transcripts were 7.5 fold increased in SET harvested 4 days after DXR (Fig. 
6), the culture data shown in Fig. 7 (panels a versus b) show that recombinant amphiregulin 
alone does not recapitulate the stimulatory effect of Day 4 SET observed in Fig. 4. Likewise, 
despite the 4.5 fold increase in chordin-like 2 expression, inhibition of BMP signaling via 
the analogous antagonist noggin was insufficient to elicit crypt budding (Fig. 7, panels c 
versus a). However in the presence of amphiregulin and noggin there was a dramatic 
stimulation of the crypts, with average bud numbers (6.3 ± 0.5 buds per enteroid) mirroring 
those seen with Day 4 SET (Fig. 4). Not only did the one-way ANOVA show significance 
of the combination treatment (Fig. 7 panel d versus c), but the two-way ANOVA showed a 
highly significant interaction of amphiregulin and noggin (p<0.001), thus documenting the 
obvious synergism between these two factors.
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In biochemical studies noggin and chordin-like 2 have been shown to have equivalent 
potencies for inhibition of purified BMP4 (Nakayama, et al., 2004) which is the principal 
BMP found in the tissue underlying intestinal crypts (Haramis, et al., 2004, He, et al., 2004). 
However, the influence of chordin-like 2 has not been previously studied in the intestinal 
epithelium. Thus, after observing the importance of BMP antagonism using noggin in Fig. 7, 
we directly compared the potency of these two BMP antagonists as facilitators of the 
proliferative response to amphiregulin. As can be seen in Fig. 8, the dose response of crypt 
budding was very similar using chordin-like 2 as compared with noggin. This indicates that 
elevated expression of chordin-like 2 in SET in vivo is likely to have a functional role in the 
regenerative response to DXR.
Time course of elevated expression of amphiregulin and chordin-like 2
In order to more carefully assess the potential roles of amphiregulin and chordin-like 2 in the 
regenerative response in vivo, we used quantitative RT-PCR to examine the time course of 
elevated expression of these factors and their family members. As can be seen in Fig. 9a, 
amphiregulin mRNA was rapidly induced, peaking at Day 2 after DXR. Transcripts of two 
other EGF family members, namely epiregulin and transforming growth factor α (TGFα), 
were also significantly elevated with a similar time course, but to only modest levels when 
compared with amphiregulin. Interestingly, EGF mRNA levels in the SET showed no 
significant change following DXR treatment. All three BMP antagonists examined (Fig. 9b) 
showed induction in response to DXR with a slower time course than the EGF family. Of 
the three, chordin-like 2 is clearly the dominant transcript with increases exceeding 25-fold 
at Day 4 and exceeding 100-fold at Day 6.
Discussion
The primary goal of this study was to characterize the role of the ISC niche in eliciting 
epithelial repair after damage from DXR. To this end, we initially determined a time point—
day 4 after DXR—in which regenerative signaling was likely to be strong. Next, we 
demonstrated increased ISC numbers and proliferation at this time, with a concomitant 
proportional increase in transit amplifying cell proliferation. We then used tightly controlled 
crypt culture conditions to show that crypts isolated from regenerating tissue (day 4 after 
DXR) were not inherently more proliferative, but that SET isolated from regenerating tissue 
was capable of enhancing enteroid budding. Transcriptome analysis of SET revealed 
candidate factors that may control epithelial responses to damage. Two of these factors, 
amphiregulin and chordin-like 2, were tested in culture and were shown to have a dramatic 
combined effect on crypt expansion.
Although previous work has demonstrated increased epithelial proliferation after DXR 
(Dekaney, et al., 2009), the focus of the current study was specifically on the ISC fraction of 
the epithelium. Our quantitative flow cytometric analysis with anti-CD24 and UEA showed 
greater than 2-fold increases in both the number of ISCs and the proportion of the ISC pool 
that were actively cycling. While there have been extensive studies on the responses of ISCs 
following radiation (Hua, et al., 2012, May, et al., 2008, Metcalfe, et al., 2014, Potten, 2004, 
Powell, et al., 2012, Van Landeghem, et al., 2012, Yan, et al., 2012, Yu, 2013), our work 
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constitutes the first detailed report of ISC behavior following DXR damage. Interestingly, 
two prior studies had pointed to the possibility that the reserve ISC fraction is activated in 
the regenerative phase after DXR treatment. First, Dekaney et al. reported increased 
numbers of side population cells (Dekaney, et al., 2009) that have subsequently been shown 
to be non-cycling under homeostatic conditions (von Furstenberg, et al., 2013). However, 
proliferation of this population in response to DXR has not been investigated. The other 
published study of ISCs after DXR is that by Buczacki et al. which reported lineage tracing 
from the label-retaining reserve ISC pool (Buczacki, et al., 2013). While this implies 
proliferation, no quantitative data were provided (in fact only a single positive mouse was 
reported). In our work, the CD24lo fraction appears to include both active and reserve ISC 
populations (Buczacki, et al., 2013, von Furstenberg, et al., 2011). As such, the increased 
EdU incorporation at day 4 after DXR likely represents both activation of the reserve ISCs 
and increased proliferation of the active ISC population. Interestingly, we found that the 
ratio of cycling ISCs to cycling TA cells was maintained between day 4 after DXR and 
untreated conditions. This suggests tight biological regulation, and merits further 
investigation into mechanisms that control this proportional expansion.
In order to assess the role of epithelial versus stromal factors in eliciting proliferation of 
ISCs after DXR damage, we turned to an in vitro approach. In recent years, Matrigel- based 
ISC and intestinal crypt cultures have emerged as powerful techniques with which to study 
ISC behavior ex vivo (Leushacke and Barker, 2014, Sato and Clevers, 2013, Sato, et al., 
2009), in the absence of the complex and intertwined forces at play in vivo. In such cultures, 
crypts initially form enterospheres that progress to budding structures termed enteroids 
(Stelzner, et al., 2012). Bud number has been established as a reliable and reproducible 
method of assessing crypt proliferation in culture (Fuller, et al., 2012). While traditional 
crypt cultures have multiple factors designed to optimize proliferation, for the current work 
we needed to minimize proliferation in order to observe the hypothesized enhancement of 
proliferation with tissues from DXR-treated mice. Similar to the report by Chen et al. using 
crypts from the distal intestine (Chen, et al., 2012), in our jejunal crypt cultures we found 
that in lieu of the standard combination of EGF, noggin and R-spondin-1, R-spondin-1 alone 
allowed survival but minimal budding.
Using these conditions, despite in vivo evidence of increased epithelial and ISC proliferation 
during repair from DXR-induced epithelial damage, we observed no difference in 
endogenous in vitro proliferative capacity of crypts isolated from mice before vs. after DXR 
damage (Fig. 4). However, the addition of SET from recovering intestine yielded a 
significant increase in enteroid budding, suggesting that regenerative stimuli may originate 
from below the epithelium. Although we have not identified which cells within the SET 
survive over the 7 days of incubation, prior studies have demonstrated that myofibroblasts 
can grow in these Matrigel cultures (Kabiri, et al., 2014, Ye Lei, et al., 2014). As discussed 
below, myofibroblasts are a likely source of the two prime candidates for eliciting crypt 
budding. To put the co-culture data in the appropriate context, a key point is that each 
enteroid bud typically has all the features of a new crypt (Sato, et al., 2009). Thus, we 
believe the process of budding is the in vitro approximate of in vivo crypt fission, which is a 
critical component of repair after damage (Wright, 2000). Moreover, since crypt fission is 
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believed to be driven by a doubling of the number of ISCs (Totafurno, et al., 1987), our 
observed SET effect suggests that by day 4 after DXR, stromal elements are secreting 
factors which enhance ISC proliferation.
Microarray analysis of the SET (Figs 5 and 6) revealed two attractive candidate factors that 
may contribute to ISC proliferation after damage. amphiregulin, a member of the EGF 
family of proteins, is known to be pro-proliferative and to play a central role in repair and 
branching morphogenesis in various tissues (Berasain and Avila, 2014). On the other hand 
chordin-like 2 is a BMP antagonist (Nakayama, et al., 2004) and thus would be expected to 
have a permissive effect on proliferation by blocking the inhibitory actions of BMP 
signaling. Prior studies in the intestine demonstrated upregulation of amphiregulin during 
regeneration after whole body irradiation, where amphiregulin production was localized to 
intestinal sub-epithelial myofibroblasts (Shao and Sheng, 2010). Further, using amphiregulin 
knockout mice, it was shown that crypt proliferation was unaltered in amphiregulin −/− mice 
at baseline but significantly hindered following irradiation, highlighting the importance of 
this molecule, specifically in the context of damage response. Chordin-like 2 has not been 
previously reported in the small intestine. However, other BMP antagonists, namely 
gremlin1, gremlin2, and chordin-like 1 have been shown to be produced by myofibroblasts 
at the bases of colonic crypts, where they are thought to enhance proliferation of epithelial 
cells, including stem cells, in that location (Kosinski, et al., 2007, Powell, et al., 2011). In 
addition, over-expression of noggin, another member of the BMP antagonist family, can 
lead to both crypt fission (Batts, et al., 2006) and de novo crypt formation (Haramis, et al., 
2004). The same outcomes are observed when BMP signaling is blocked by ablation of 
BMP receptors (Auclair, et al., 2007, He, et al., 2004).
Based on this literature, we expected amphiregulin to increase proliferative activity of 
jejunal crypts in vitro and for BMP antagonism to possibly enhance this effect. Interestingly, 
under the culture conditions used (Fig. 7), addition of recombinant amphiregulin alone did 
not increase enteroid budding. However, in the presence of both amphiregulin and BMP 
antagonism (using either noggin or chordin-like 2), there was dramatic stimulation, yielding 
bud numbers equivalent to those seen during co-culture with SET isolated 4 days after DXR 
(Fig. 4). The fact that the proliferative effect of amphiregulin only became apparent when 
BMP signaling was inhibited, implies presence of BMPs in this culture system. Since 
stromal elements, which are the usual source of BMPs in vivo (Haramis, et al., 2004, He, et 
al., 2004), were not included in the study shown in Fig. 7, the most likely source of BMPs is 
the Matrigel (Paralkar, et al., 1992). In intact tissue, endogenous BMPs in the lamina propria 
would play an analogous role. Thus, we propose that the increases in expression of 
amphiregulin and chordin-like 2 observed in SET in vivo are responsible for the increased 
ISC proliferation observed at day 4 after DXR. Confirmation of this suggestion will require 
demonstration that pharmacologic or genetic ablation of amphiregulin or chordin-like 2 
prevents the ISC regenerative response following DXR. Such studies are a logical future 
direction.
Our qRT-PCR study revealed some interesting nuances (Fig. 9). First, within the EGF 
family, two other members, namely epiregulin and TGFα, were up-regulated following 
DXR. Transcript levels of all three EGF family members peaked at Day 2 and remained 
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elevated at Day 4. However, at both these time points it was clear that amphiregulin was the 
dominant mRNA, with induced levels being 5–6-fold and 9–12-fold higher than those of 
epiregulin and TGFα, respectively. Likewise, although statistical analyses indicated that the 
three BMP antagonists (chordin-like 2, gremlin 1, and noggin) were all up-regulated in 
response to DXR damage, only chordin-like 2 displayed a robust increase likely to have 
biological significance. Taken together, our findings point to a novel mechanism that may be 
critical for repair of the intestinal epithelium following various insults. Further, our 
demonstration of the potent synergism between amphiregulin and BMP antagonism in 
stimulation of enteroid budding in vitro, suggests that in vivo these two pathways may 
provide the driving force for ISC activation and, subsequently, restoration of crypt number 
via crypt fission. The fact that the surge of chordin-like 2 expression was delayed as 
compared with that of amphiregulin suggests continued BMP antagonism may be important 
in allowing the progression from ISC activation to crypt fission. Further studies to elucidate 
the cellular and molecular biology of these processes are clearly warranted, and have 
obvious translational applications.
While our transcript analyses of SET following DXR led us to focus on two families of 
factors that are likely secreted by myofibroblasts, we recognize that the cellular response to 
the DXR damage is complex. For example, one cannot overlook the importance of the 
inflammatory reaction elicited by epithelial compromise, and the role that immune cells play 
in orchestrating tissue responses. Indeed, blinded scoring of tissue sections following DXR 
revealed an acute inflammatory response (see high power images in Supplemental Fig. 1). 
The possibility that these immune cells influence ISC behavior, either by direct signaling to 
ISCs, or by indirect signaling though myofibroblasts or other cell types, deserves further 
attention, but was beyond the scope of the current study.
Looking to the future, our current findings, together with previous work that has pointed to 
reserve ISCs as being the regenerative source of new crypts, suggest two translational 
applications. The first is the combined delivery of an EGF family member with a BMP 
antagonist to accelerate the in vivo activation of reserve ISCs following intestinal damage, 
thus limiting the extent and duration of epithelial compromise. The second is the use of 
similar combinations of these factors to propagate reserve ISCs in vitro for use in 
transplantation. To date, ISC culture protocols have been optimized for expansion of the 
active subpopulation of ISCs. While reserve ISCs typically grow under these conditions, 
their biology may be abnormal. Thus, full exploration of the signaling pathways operative in 
vivo, and application of these to generate culture conditions that preserve normal behavior of 
the reserve ISC fraction, may be of significant value to the field of tissue engineering.
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Damage and repair of jejunum after doxorubicin (DXR). a: Animal weight loss after IP 
injection of DXR, where Day 0 represents the reference point for each mouse before DXR 
injection. b–f: Quantitative analysis of crypt number, jejunal circumference, crypt depth, 
crypt width, and crypt fission over time after DXR, with data at Days 2, 4, 6 and 8 showing 
DXR-injected mice and Day 0 showing control uninjected mice. g: Representative images of 
crypt morphology (10x), with scale bar equivalent to 50μm and with crypt fission denoted 
by the white arrow. Bar graphs plotted as mean ± SEM (n ≥ 3 for each time point). Asterisks 
show comparison with day 0 (i.e. no DXR). *p <0.05, **p <0.01, ***p <0.001.
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Intestinal stem cell (ISC) numbers and proliferation status are elevated 4 days after 
doxorubicin (DXR). a: Flow cytometry was used to identify non-cycling ISCs (CD24lo/
UEA−/EdU−) denoted by solid blue gate, cycling ISCs (CD24lo/UEA−/EdU+) dashed blue 
gate, and cycling transit amplifying cells (UEA−/CD24−/Edu+) dashed orange gate. Cells 
displayed in this panel were depleted of UEA+ cells in prior gate (not shown), b: Marker 
strategy used for identification of total ISCs, cycling ISCs, and (TA) cells, c: The 
contribution of ISCs as a percent of total epithelium before (n=6) and 4 days after DXR 
(n=7), d: Percent of ISCs cycling before and after DXR, e: The ratio of ISCs to transit 
amplifying cells before and after DXR. Bar graphs plotted as mean ± SEM. *p <0.05. TA- 
Transit Amplifying; Pc- Paneth cell
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Establishing minimal crypt culture conditions. a: The effect of different conditions on crypt 
survival over 7d (solid bars) and on bud number per enteroid at 7d (open bars); b,c: 
Representative images of crypt progression after 7d in culture under routine Sato conditions 
(ENR) vs. R alone (10x). Bar graphs plotted as mean ± SEM (n=2–3). Asterisks show 
comparison with ENR. *p <0.05. **p<0.01. E- Epidermal Growth Factor; N- noggin; R- R-
spondin-1
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Endogenous proliferation of crypts, and the effect of sub-epithelial tissue (SET) on crypt 
budding. The average bud number of crypts after 1 week in culture is shown across 4 culture 
conditions, with representative images: a: Control (untreated) crypts (n=8), b: Day 4 after 
doxorubicin (DXR) crypts (n=7), c: Co-culture of control crypts + control SET (n=8), d: Co-
culture of control crypts + day 4 after DXR SET (n=7). All images 10X with bar showing 
100 μm. Graphs plotted as mean ± SEM. *p<0.05.
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Microarray analysis of sub-epithelial tissue (SET). Microarray heat map of SET from 
untreated control mice (n=8) vs. SET from mice on day 4 after doxorubicin (DXR) (n=8). 
Each lane represents an individual mouse and results of hierarchical clustering are shown 
above the lanes. Upregulated and downregulated genes are indicated by red and blue, 
respectively.
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Gene Ontology (GO) analysis of sub-epithelial tissue (SET) microarray data. Panels a and b 
show the most abundant enriched categories within the biological properties and cellular 
component arms of GO. Panel c identifies regenerative candidates by cross comparison of 
relevant GO categories. Panel d shows the fold increase of the 10 transcripts identified in 
Panel c and arrows show the 2 secreted factors chosen to study with cultured crypts, i.e. 
amphiregulin and chordin-like 2.
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Effects of amphiregulin and BMP antagonism on crypts in culture. Control (untreated) 
crypts were grown for 7 days under minimal conditions established in Fig. 3 with: a: No 
added factors; b: amphiregulin (A) alone; c: Noggin (N) alone; and d: Both amphiregulin 
and noggin. Top panels show representative images with bars showing 500 μm and lower 
panel shows buds per enteroid as means ± SEM, n=5 per condition. ***p<0.001; compared 
with condition a.
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Dose response of chordin-like 2 in comparison with noggin on crypts in culture. Control 
crypts were grown for 7 days under minimal conditions established in Fig. 3 with added 
amphiregulin as in Fig. 7 and with various concentrations of either noggin (NOG) or 
chordin-like 2 (CHRDL2). Each panel shows buds per enteroid as means ± SEM, n=2. Two-
way ANOVA showed a significant effect of dose (p<0.001); but no significant difference 
between noggin and chordin-like-2 (p>0.1) and no significant interaction (p>0.4)
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Quantitative RT-PCR analysis of RNA from SET harvested at 2, 4, 6, and 8 days following 
DXR administration for select EGF family members and BMP antagonists relative to 
untreated SET. a: EGF members shown include amphiregulin (Areg), epiregulin (Ereg), and 
transforming growth factor, alpha (Tgfa). b: Inhibitors of BMP analyzed include chordin-
like 2 (Chrdl2), gremlin 1 (Grem1), and noggin (Nog). Bars show mean ± SEM, n = 3–5. All 
factors shown have p < 0.05 by one-way ANOVA.
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